SDGR
Schrödinger, Inc.NASDAQHealthcare$11.58+0.26%ClosedMarket Cap: $854.9M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
2.34
P/S
3.34
EV/EBITDA
-8.56
DCF Value
$-47.39
FCF Yield
1.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
55.7%
Operating Margin
-65.2%
Net Margin
-40.4%
ROE
-29.5%
ROA
-14.3%
ROIC
-30.2%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $87.2M | 65.7% | $-17.2M | $32.5M | $0.44 | — |
| FY 2025 | $255.9M | 55.7% | $-166.9M | $-103.3M | $-1.41 | — |
| Q3 2025 | $54.3M | 51.6% | $-45.9M | $-32.8M | $-0.45 | — |
| Q2 2025 | $54.8M | 47.8% | $-52.9M | $-43.2M | $-0.59 | — |
| Q1 2025 | $59.6M | 52.3% | $-50.9M | $-59.8M | $-0.82 | — |
| Q4 2024 | $88.3M | 72.6% | $-20.7M | $-40.2M | $-0.55 | — |
| FY 2024 | $207.5M | 63.6% | $-209.3M | $-187.1M | $-2.57 | — |
| Q3 2024 | $35.3M | 50.2% | $-68.4M | $-38.1M | $-0.52 | — |
| Q2 2024 | $47.3M | 66.2% | $-52.7M | $-54.0M | $-0.74 | — |
| Q1 2024 | $36.6M | 51.6% | $-67.4M | $-54.7M | $-0.76 | — |
| Q4 2023 | $74.1M | 77.6% | $-29.6M | $-30.7M | $-0.43 | — |
| FY 2023 | $216.7M | 64.9% | $-177.4M | $40.7M | $0.54 | — |